Nottingham Respiratory Research Unit

IPF is a progressive and devastating lung disorder characterised by irreversible scarring (fibrosis) of the lung. IPF affects over 8,000 peo

Many research groups around the world use thin slices of lung tissue to investigate asthma and other respiratory diseases. Lung slices...

Klaudia Kaczmarek is a PhD student working in Nottingham City Hospital, supervised by Professor Alan Knox and Dr Rachel Clifford . Her...

Idiopathic pulmonary fibrosis (IPF) is a long-term chest condition that is characterised by fibrosis (scarring) of the lungs, which...

I am interested in the epigenetics of lung disease, primarily asthma. Epigenetics refers to a group of processes that control how and...

Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease with poor survival rates and limited treatment options. Upregulati

Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGFβ1 is considered central to the pa